EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antagonist nanobodies prevent protease inhibition by CD109

Kathrine Tejlgård Jensen, Ana Viana Almeida, Sanne Rönning, Maximillian Karlander, Nadia Sukusu Nielsen, Ida B Thøgersen, Magdalena Malm, Gregers Rom Andersen, Jan J Enghild, Johan Rockberg, Seandean Lykke Harwood

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.111187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von Kathrine Tejlgård Jensen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark. Hauptthemen laut MEDLINE: Antigens, CD, Single-Domain Antibodies, Neoplasm Proteins, Protease Inhibitors. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novo Nordisk Foundation, Sweden's Innovation Agency, Velux Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CDSingle-Domain AntibodiesNeoplasm ProteinsProtease InhibitorsPeptide HydrolasesHumansHEK293 CellsGPI-Linked Proteins

Stichwörter der Autor:innen

CD109antagonistantibodycomplement familyinhibition mechanismproteaseprotease inhibitorprotein conformationsingle-domain antibodythioesterthiol ester

Substanzen

Antigens, CDSingle-Domain AntibodiesGPI-Linked ProteinsCD109 protein, humanNeoplasm ProteinsProtease InhibitorsPeptide Hydrolases

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.
  • Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
  • Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark. Electronic address: sdlh@mbg.au.dk.

Förderung

  • Novo Nordisk Foundation
  • Sweden's Innovation Agency
  • Velux Foundation
  • Velux Stiftung
  • Independent Research Fund Denmark
  • Dagmar Marshalls Fond

Zitieren

APA

Jensen, K. T., Almeida, A. V., Rönning, S., Karlander, M., Nielsen, N. S., Thøgersen, I. B., Malm, M., Andersen, G. R., Enghild, J. J., Rockberg, J., & Harwood, S. L. (2026). Antagonist nanobodies prevent protease inhibition by CD109. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111187

Vancouver

Jensen KT, Almeida AV, Rönning S, Karlander M, Nielsen NS, Thøgersen IB, et al. Antagonist nanobodies prevent protease inhibition by CD109. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111187

BibTeX
@article{Jensen2026,
  author = {Jensen, Kathrine Tejlgård and Almeida, Ana Viana and Rönning, Sanne and Karlander, Maximillian and Nielsen, Nadia Sukusu and Thøgersen, Ida B and Malm, Magdalena and Andersen, Gregers Rom and Enghild, Jan J and Rockberg, Johan and Harwood, Seandean Lykke},
  title = {Antagonist nanobodies prevent protease inhibition by CD109},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.111187}
}
Kostenlos starten →